My areas of expertise include computational chemistry, molecular modeling, structure-based drug discovery, molecular docking, molecular dynamics simulations, free energy calculations, and bioinformatics. My research primarily focuses on identifying and evaluating natural and synthetic compounds against drug-resistant targets of Mycobacterium tuberculosis, including MDR/XDR-associated proteins involved in DNA replication, cell wall biosynthesis, and energy metabolism. I also have experience in protein structure prediction, homology modeling, pharmacokinetics/toxicity analysis, and machine learning-assisted drug discovery workflows. Additionally, I have contributed to interdisciplinary research in enzymology, therapeutic proteins, and natural product-based therapeutics, with several peer-reviewed publications in related fields.